The data gathered from this study indicate elevated levels of IL-4 in the Doc-resistant cell line upon stimulation with Doc aligns with the findings of Perambakam et al. [83] and Takeshi et al. [84], and reinforces the involvement of IL-4 in the tumor growth of resistant cells. Here, IL4 is linked to neoplasm.